Novo Nordisk says its obesity drug in higher dose shows 20.7% weight loss
Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...
New Scientist on MSN2d
A new definition of obesity could help treat millions of people
Obesity is typically assessed by measuring someone's body mass index, but now researchers are calling for a more nuanced ...
Medical News Today7h
Why BMI is not the obesity measurement we need
A global group of experts has suggested a new approach to diagnosing and treating obesity that does not rely solely on the much-contested body mass index (BMI).
New recommendations to measure obesity go beyond controversial BMI
Body Mass Index, or BMI, has long been criticized as an unreliable method for measuring obesity — and now a group of experts ...
The Economist2d
Is obesity a disease?
By coincidence (they started before GLP -1 drugs were approved for slimming), a group of 56 doctors have just answered that ...
New guidelines encourage doctors to move beyond BMI for diagnosing obesity
A new report says only using BMI to determine if a patient has obesity leads to under-diagnosing people who are ill and ...
East Idaho News on MSN52m
Ozempic and Wegovy selected for next round of Medicare drug price negotiations
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
Protagonist Therapeutics chief medical officer sells shares for tax obligations
Officer of Protagonist Therapeutics, Inc. (NASDAQ:PTGX), a $2.2 billion market cap biotech company, recently reported the sale of 3,640 shares of common stock on January 16, 2025. The transactions ...